Abstract
Orally administered SKI-O-703, a new Syk inhibitor, reduces lupus nephritis-like manifestations in NZB/W mice. Spleen tyrosine kinase (Syk) plays a pi......
小提示:本篇文献需要登录阅读全文,点击跳转登录